Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
79.43B | 72.98B | 70.93B | 73.89B | 71.22B | Gross Profit |
19.79B | 12.97B | 17.39B | 21.90B | 19.96B | EBIT |
3.18B | -2.95B | 2.01B | 6.01B | 3.92B | EBITDA |
11.34B | 5.16B | 8.99B | 12.99B | 11.13B | Net Income Common Stockholders |
3.52B | -2.04B | 2.53B | 4.04B | 1.53B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
14.92B | 16.03B | 12.48B | 13.89B | 12.18B | Total Assets |
103.50B | 104.90B | 104.93B | 100.24B | 100.60B | Total Debt |
32.28B | 39.70B | 36.91B | 32.03B | 35.33B | Net Debt |
18.65B | 23.67B | 24.43B | 18.14B | 23.16B | Total Liabilities |
48.68B | 53.94B | 50.42B | 46.10B | 50.06B | Stockholders Equity |
54.82B | 50.95B | 54.51B | 54.14B | 50.54B |
Cash Flow | Free Cash Flow | |||
6.16B | 3.10B | -4.54B | 6.48B | 8.05B | Operating Cash Flow |
8.38B | 4.67B | 5.85B | 10.47B | 10.78B | Investing Cash Flow |
1.05B | -4.15B | -11.61B | -4.33B | -2.90B | Financing Cash Flow |
-8.79B | 888.00M | 3.01B | -4.80B | -4.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥144.78B | 7.85 | 2.10% | 15.82% | 128.09% | ||
68 Neutral | ¥57.10B | 11.36 | 2.73% | 6.12% | 344.71% | ||
67 Neutral | ¥16.50B | 13.31 | 2.33% | 5.36% | 2.53% | ||
64 Neutral | $8.79B | 14.77 | 5.05% | 174.29% | 3.63% | 3.48% | |
56 Neutral | ¥45.22B | 23.61 | 1.05% | 12.65% | 21.05% | ||
43 Neutral | ¥4.12B | ― | 1.02% | 5.53% | -128.84% |
Hokuto Corporation has completed the payment process for the disposal of its treasury shares as restricted stock compensation for its executive officers. This move, resolved in November 2024, involves the disposal of 6,770 common shares at a price of ¥1,773 per share, amounting to a total value of ¥12,003,210, and is aimed at aligning the interests of the executive officers with those of the shareholders.
Hokuto Corporation has received certification from the SCFA Promotion Association for its maitake mushrooms, recognizing their potential to contribute to SCFA production in the human intestine. This certification allows Hokuto to include the SCFA Certification Mark on its maitake mushroom packaging starting May 2025, enhancing its market positioning by highlighting the health benefits of its products.
Hokuto Corporation, in partnership with Riken Vitamin Co., Ltd., has developed a new mushroom extract from unused parts and off-grade bunashimeji mushrooms, for which they were granted a patent in November 2024. This innovation, which supports sustainable production, is already being used in Riken Vitamin’s products, with plans for broader application. This development marks a significant advancement in utilizing natural resources efficiently, reinforcing both companies’ commitment to sustainability and health-oriented products.
Hokuto Corporation reported a significant increase in its financial performance for the nine months ended December 31, 2024, with net sales rising by 5.2% and operating profit surging by 182.1% compared to the previous year. The company also revised its earnings forecasts upward, indicating strong growth expectations, which may positively impact stakeholders and enhance its competitive position in the food industry.
Hokuto Corporation reported a robust financial performance for the nine months ending December 31, 2024, with significant increases in operating profit and profit attributable to owners of the parent. The company’s net sales grew by 5.2% year-on-year, and operating profit rose by 182.1%, indicative of strong operational efficiencies and market demand for its products. This financial upturn highlights Hokuto’s strengthened position in the industry and could potentially lead to increased investor confidence.
Hokuto Corporation has revised its financial forecasts for the fiscal year ending March 31, 2025, projecting significant increases in net sales, operating profit, ordinary profit, and profit attributable to owners of the parent, driven by higher mushroom prices and lower manufacturing costs. Additionally, the company updated its dividend forecast, increasing the year-end dividend per share from previous estimates, reflecting its strong financial performance.